Tumor hypoxia, reoxygenation and oxygenation strategies: possible role in photodynamic therapy.
The concept of hypoxia and its role in tumor therapy are currently under re-evaluation. Poor oxygenation is no longer visualized as an independent feature promoting necrosis and resistance to treatments, but rather as one of the several interdependent microenvironmental parameters associated with impaired blood perfusion. Tumor cells display several survival strategies and remain clonogenic for long periods in nutrient-deprived situations. Reoxygenation may cause lethal damage, improve the response to therapy, or else allow the cell variants adapted to hypoxia to resume proliferation with enhanced aggressiveness and resistance to treatment. The blood supply parameters, oxygenation status and metabolism of malignant cells are discussed here from the standpoint of tumor photodynamic therapy. The role of the tumor interstitial fluid as oxygen- and sensitizer-carrier is discussed. Techniques for assessing tumor oxygenation and for mapping hypoxic territories are described. Strategies for locally improving the oxygenation levels or for selectively destroying the hypoxic populations are outlined.
Freitas
I
I
Department of Animal Biology, University of Pavia, Italy.
Baronzio
G F
GF
D006801:Humans; D000860:Hypoxia / Q000503:physiopathology*; D009336:Necrosis; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D010101:Oxygen Consumption; D010778:Photochemotherapy; D012039:Regional Blood Flow